< Back to latest news & events

Event

IP in Healthcare Conference 2020

March 2020

Event date: 3rd March 2020

March 2020 in London and Manchester. HGF’s sixth annual Healthcare Conference reviews the latest intellectual property issues in the pharmaceuticals, life sciences and medical devices sectors.

Update

It is with great regret that we have taken the decision to cancel the HGF IP in Healthcare conference in London on Thursday 12th March. This is a precautionary measure by the firm based on current situation surrounding the Coronavirus in the UK and Europe.

We would like to take this opportunity to thank you for reserving your place and we look forward to welcoming you again in 2021.

Dates

The Conference will take place on the following dates:

  • Tuesday 3rd March in Alderley Park, Manchester
  • Thursday 12th March in Barber-Surgeons Hall, London *Cancelled*
About HGF Healthcare team

HGF’s Healthcare team provides professional expertise and commercially focused advice to business leaders and decision makers in the healthcare fields of life sciences, pharmaceuticals and medical devices. HGF has in-depth knowledge of the sector, and the experience to provide you with high quality and commercially focused advice in relation to the protection of your IP rights. The team offers the full range of IP services including:

  • IP strategy and advice;
  • Patent and trade mark procurement;
  • IP portfolio management;
  • Freedom-to-operate advice and opinions;
  • IP due diligence assessments and opinions;
  • Supplementary protection certificates and data exclusivity advice;
  • IP licences and agreements;
  • IP disputes management and litigation

For more information on the team please click here.

Please join our Healthcare+IP LinkedIn group which discusses stories and legal developments in the intellectual property field which impacts the healthcare sector.

Latest updates

UK IPO fees to increase from 1 April 2026

Whilst the fee changes are subject to parliamentary approval, they are almost certain to take effect – read on to learn more. The United Kingdom Intellectual Property Office (UK IPO) …

Read article

Mycelium Meets Market Reality: The Quiet Role of IP in Scaling Sustainable Materials

Fungal materials are increasingly used in applications ranging from sustainable packaging and leather alternatives to construction composites, textiles, and biotechnology. These developments are transforming fungi from a niche research subject …

Read article
Event - 24th - 25th November 2025

HGF Partners with 3AF for the P2I2025 Symposium

HGF are pleased to be a partner of P2I2025, the annual symposium organised by the Intellectual Property Commission of the French Aeronautics and Astronautics Association (3AF). The event brings together …

Event details

Retailers liability and AI Applications

The question of whether the user (consumer) or the provider of an AI application is liable for the infringement of intellectual property rights as a result of the use of …

Read article
Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article